Very nice. love the bit at the end
BARD1 is currently in discussions with a number of contract laboratory organisations that have specialty expertise in assay development and validation to transfer the BARD1 research essay to a commercial platform that will enable the BARD1 tests to be performed by most hospital and independent clinical laboratories around the world. “BARD1 anticipates that transfer of our research assay to a commercial platform will enable more efficient development and commercialisation of our diagnostic pipeline for detection of lung, ovarian and other cancers,” said Dr Leearne Hinch, BARD1 CEO.
When this happens this will blow.
patience, long term hold will be rewarded.
- Forums
- ASX - By Stock
- IIQ
- Ann: Additional BARD1 Ovarian Test Results
Ann: Additional BARD1 Ovarian Test Results, page-2
-
- There are more pages in this discussion • 243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
58.5¢ |
Change
0.020(3.54%) |
Mkt cap ! $64.51M |
Open | High | Low | Value | Volume |
57.0¢ | 60.5¢ | 57.0¢ | $30.40K | 51.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 0.575 |
1 | 14035 | 0.570 |
2 | 12000 | 0.560 |
5 | 18564 | 0.555 |
3 | 53619 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 290 | 1 |
0.600 | 9950 | 5 |
0.610 | 23519 | 4 |
0.620 | 16167 | 2 |
0.625 | 1584 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online